Science moves forward on data. We all know this. But bad data leads science down dead ends. It wastes time. It wastes money.

Research presented by Dr Erik Sahai has shown that early, reversible diversity in tumour cell state can blunt the effect of ...

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.

For decades, schizophrenia and bipolar disorder have been diagnosed from the outside in, through behavior, mood, and memory rather than the cells and circuits that go wrong. Now a new wave of brain ...

Arista Networks leverages AI and data center growth, posting strong earnings and innovation, but high valuation may limit ...